FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1935312565> ?p ?o ?g. }

• W1935312565 endingPage "305" @default.
• W1935312565 startingPage "296" @default.
• W1935312565 abstract "Please cite this paper as: Hussain A, Steimle M, Hoppeler H, Baum O, Egginton S. The vascular-disrupting agent combretastatin impairs splitting and sprouting forms of physiological angiogenesis. Microcirculation 19: 296–305, 2012. Abstract Objective: Vascular-disrupting agents like combretastatin (CA-4-P), used to attenuate tumor blood flow in vivo, exert anti-mitotic and anti-migratory effects on endothelial cells in vitro. We tested whether anti-vascular or anti-angiogenic effects of CA-4-P are evident with physiological angiogenesis in skeletal muscle (EDL) due to sustained hyperemia (intraluminal splitting) and chronic muscle overload (abluminal sprouting). Methods: CA-4-P was given i.v. (25 mg/kg on alternate days for 14 days) to mice subjected to angiogenic stimuli (prazosin or synergist extirpation). The responses of femoral artery blood flow as well as capillarity, capillary ultrastructure, and levels of Rho GTPase were measured. Results: Blood flow was unaffected in the sprouting angiotype, but decreased in the splitting angiotype, by CA-4-P. In contrast, CA-4-P attenuated the capillarity increase in both models, associated with reduced lamellipodia and filopodia formation. Muscle overload, but not hyperemia, was accompanied by an increase in Rho GTPase with CA-4-P. Conclusions: CA-4-P impaired the angiogenic response in both experimental models. This inhibitory effect was associated with a lower increase in femoral blood flow in splitting, whereas sprouting angiogenesis was accompanied by higher Rho activity consistent with the interruption of actin polymerization. Thus, CA-4-P may exert context-dependent anti-vascular and anti-angiogenic effects in vivo under physiological conditions." @default.
• W1935312565 created "2016-06-24" @default.
• W1935312565 creator A5001626218 @default.
• W1935312565 creator A5009576240 @default.
• W1935312565 creator A5019839612 @default.
• W1935312565 creator A5064007217 @default.
• W1935312565 creator A5084132202 @default.
• W1935312565 date "2012-04-24" @default.
• W1935312565 modified "2023-09-23" @default.
• W1935312565 title "The Vascular-Disrupting Agent Combretastatin Impairs Splitting and Sprouting Forms of Physiological Angiogenesis" @default.
• W1935312565 cites W1516793862 @default.
• W1935312565 cites W1576876113 @default.
• W1935312565 cites W1639784955 @default.
• W1935312565 cites W1967435469 @default.
• W1935312565 cites W1970048663 @default.
• W1935312565 cites W1970242273 @default.
• W1935312565 cites W1974934240 @default.
• W1935312565 cites W1988922198 @default.
• W1935312565 cites W1988956777 @default.
• W1935312565 cites W2000000541 @default.
• W1935312565 cites W2000688337 @default.
• W1935312565 cites W2019927236 @default.
• W1935312565 cites W2024304301 @default.
• W1935312565 cites W2032100189 @default.
• W1935312565 cites W2037999044 @default.
• W1935312565 cites W2042148981 @default.
• W1935312565 cites W2056944384 @default.
• W1935312565 cites W2066782344 @default.
• W1935312565 cites W2085049116 @default.
• W1935312565 cites W2091844981 @default.
• W1935312565 cites W2102782790 @default.
• W1935312565 cites W2112203191 @default.
• W1935312565 cites W2117241329 @default.
• W1935312565 cites W2128773741 @default.
• W1935312565 cites W2135723950 @default.
• W1935312565 cites W2143591410 @default.
• W1935312565 cites W2148990197 @default.
• W1935312565 cites W2153161317 @default.
• W1935312565 cites W2164321835 @default.
• W1935312565 cites W2221719760 @default.
• W1935312565 doi "https://doi.org/10.1111/j.1549-8719.2012.00160.x" @default.
• W1935312565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22236138" @default.
• W1935312565 hasPublicationYear "2012" @default.
• W1935312565 type Work @default.
• W1935312565 sameAs 1935312565 @default.
• W1935312565 citedByCount "6" @default.
• W1935312565 countsByYear W19353125652015 @default.
• W1935312565 countsByYear W19353125652016 @default.
• W1935312565 countsByYear W19353125652017 @default.
• W1935312565 countsByYear W19353125652018 @default.
• W1935312565 countsByYear W19353125652020 @default.
• W1935312565 crossrefType "journal-article" @default.
• W1935312565 hasAuthorship W1935312565A5001626218 @default.
• W1935312565 hasAuthorship W1935312565A5009576240 @default.
• W1935312565 hasAuthorship W1935312565A5019839612 @default.
• W1935312565 hasAuthorship W1935312565A5064007217 @default.
• W1935312565 hasAuthorship W1935312565A5084132202 @default.
• W1935312565 hasConcept C126322002 @default.
• W1935312565 hasConcept C12722491 @default.
• W1935312565 hasConcept C134018914 @default.
• W1935312565 hasConcept C150903083 @default.
• W1935312565 hasConcept C151730666 @default.
• W1935312565 hasConcept C185592680 @default.
• W1935312565 hasConcept C20418707 @default.
• W1935312565 hasConcept C207001950 @default.
• W1935312565 hasConcept C2778271429 @default.
• W1935312565 hasConcept C2778275628 @default.
• W1935312565 hasConcept C2779343474 @default.
• W1935312565 hasConcept C2780394083 @default.
• W1935312565 hasConcept C2910429298 @default.
• W1935312565 hasConcept C71924100 @default.
• W1935312565 hasConcept C84425145 @default.
• W1935312565 hasConcept C86803240 @default.
• W1935312565 hasConcept C95444343 @default.
• W1935312565 hasConceptScore W1935312565C126322002 @default.
• W1935312565 hasConceptScore W1935312565C12722491 @default.
• W1935312565 hasConceptScore W1935312565C134018914 @default.
• W1935312565 hasConceptScore W1935312565C150903083 @default.
• W1935312565 hasConceptScore W1935312565C151730666 @default.
• W1935312565 hasConceptScore W1935312565C185592680 @default.
• W1935312565 hasConceptScore W1935312565C20418707 @default.
• W1935312565 hasConceptScore W1935312565C207001950 @default.
• W1935312565 hasConceptScore W1935312565C2778271429 @default.
• W1935312565 hasConceptScore W1935312565C2778275628 @default.
• W1935312565 hasConceptScore W1935312565C2779343474 @default.
• W1935312565 hasConceptScore W1935312565C2780394083 @default.
• W1935312565 hasConceptScore W1935312565C2910429298 @default.
• W1935312565 hasConceptScore W1935312565C71924100 @default.
• W1935312565 hasConceptScore W1935312565C84425145 @default.
• W1935312565 hasConceptScore W1935312565C86803240 @default.
• W1935312565 hasConceptScore W1935312565C95444343 @default.
• W1935312565 hasIssue "4" @default.
• W1935312565 hasLocation W19353125651 @default.
• W1935312565 hasLocation W19353125652 @default.
• W1935312565 hasOpenAccess W1935312565 @default.
• W1935312565 hasPrimaryLocation W19353125651 @default.
• W1935312565 hasRelatedWork W1935312565 @default.
• W1935312565 hasRelatedWork W2053860153 @default.

• next